EP Patent

EP1291021A2 — Pharmaceutical formulations for thyroid hormones

Assigned to Altergon SA · Expires 2003-03-12 · 23y expired

What this patent protects

The present invention provides for pharmaceutical formulations based on thyroid hormones enabling a safe and stable oral administration in the framework of the strict therapeutic index prescribed in case of thyroid disorders.

USPTO Abstract

The present invention provides for pharmaceutical formulations based on thyroid hormones enabling a safe and stable oral administration in the framework of the strict therapeutic index prescribed in case of thyroid disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP1291021A2
Jurisdiction
EP
Classification
—
Expires
2003-03-12
Drug substance claim
No
Drug product claim
No
Assignee
Altergon SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.